Trials / Completed
CompletedNCT00532246
Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo
A Study of Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene HCl or Placebo
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 147 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to measure carotid artery IMT at a single visit in a subset of women previously enrolled in the CORE (H3S-MC-GGJY) trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | raloxifene | |
| DRUG | Placebo |
Timeline
- Start date
- 2003-03-01
- Completion
- 2003-08-01
- First posted
- 2007-09-20
- Last updated
- 2007-09-20
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00532246. Inclusion in this directory is not an endorsement.